Related Experiment Video
Updated: Mar 20, 2026
12:03
Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
18.5K
Angiotensin-converting enzyme (ACE-I/D) polymorphism frequency in Brazilian soccer players
Daniel Barbosa Coelho1, Eduardo Pimenta2, Izinara Cruz Rosse3
1a Sports Center, Federal University of Ouro Preto, CEP-35400-000 Minas Gerais, Brazil.
Summary
This study examined angiotensin-converting enzyme (ACE-I/D) gene variations in Brazilian soccer players across various age groups. No significant differences in ACE-I/D allele or genotype frequencies were found compared to a control group.
Area of Science:
- Sports Science
- Genetics
- Human Physiology
Background:
- The angiotensin-converting enzyme (ACE) gene, specifically the I/D polymorphism, is investigated for its potential role in athletic performance.
- Understanding the genetic makeup of elite athletes can provide insights into performance-related traits.
Purpose of the Study:
- To determine the allelic and genotypic frequencies of the ACE gene (I/D polymorphism) in Brazilian soccer players of different age categories.
- To compare these frequencies with a control group to identify any potential genetic associations with soccer participation in Brazil.
Main Methods:
- Genotyping of the ACE I/D polymorphism was performed on 353 Brazilian soccer players.
- Players were categorized into Under-14, Under-15, Under-17, Under-20, and professional levels.
- Allelic and genotypic frequencies were statistically compared between player categories and a control group.
Main Results:
- No statistically significant differences were observed in ACE-I/D allelic frequencies across any of the player age categories when compared to the control group.
- Similarly, no significant differences in ACE-I/D genotypic frequencies were found between the soccer players and the control group.
- This marks the first investigation into ACE-I/D polymorphism specifically within Brazilian soccer players.
Conclusions:
- The ACE-I/D polymorphism does not appear to be a significant factor differentiating Brazilian soccer players from the general population across various age groups.
- Further research may be warranted to explore other genetic markers or environmental factors influencing soccer talent in Brazil.
Related Concept Videos
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.8K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.8K
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
65
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
65
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.4K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
3.0K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
3.0K
01:25Antihypertensive Drugs: Direct Renin Inhibitors
1.7K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.7K
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
102
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
102